[The clinical efficacy of the combined drug agent Valcophen in children].
Children affected by acute virus respiratory infection running its course with characteristic symptoms of rhinitis, pharyngitis, tonsillitis, and acute bronchitis were administered combination therapy with a new pharmaceutical valcophen in a tablet form. In a clinical trial of the above drug, gratifying therapeutic results were found to be obtainable with a 2-to-3 day course of treatment at minimum dosage.
Shapovalova
V A
VA
Shapovalov
V V
VV
D000208:Acute Disease; D000293:Adolescent; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use*; D002110:Caffeine / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D009497:Neurotic Disorders / Q000150:complications; D010634:Phenobarbital / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013607:Tablets; D014777:Virus Diseases / Q000188:drug therapy
D000894:Anti-Inflammatory Agents, Non-Steroidal; D004338:Drug Combinations; D013607:Tablets; C116569:valcophen; D002110:Caffeine; D001241:Aspirin; D010634:Phenobarbital
Klinichna efektyvnist' kombinovanoho likars'koho zasobu "Val'kofen" u diteĭ.